ArticleCancers2019

L19-IL2 Immunocytokine in Combination with the Anti-Syndecan-1 46F2SIP Antibody Format: A New Targeted Treatment Approach in an Ovarian Carcinoma Model.

Paola Orecchia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.